摘要
目的对昆明市乙型病毒性肝炎(乙肝)、甲型病毒性肝炎(甲肝)、伤寒等疫苗接种进行成本效益分析,为昆明市针对不同疫苗、不同人群制定免疫接种策略提供科学依据。方法通过调查问卷收集昆明市近年来甲肝、乙肝、伤寒疫苗可预防传染病患者医疗费用资料,进行疫苗接种成本效益比值(BCR)分析。结果本研究共调查样本12563例,其中甲肝1337例、乙肝1881例、伤寒941例。根据疫苗接种的成本效益分析,接种甲肝疫苗的BCR=1.79,每年可避免1827人发病,每年产生净效益1578.98万元;接种乙肝疫苗的BCR=1.80,每年可避免3546人成为乙肝病毒感染者,减少77877.74个工作日的损失,每年产生净效益3002.40万元;接种伤寒疫苗的BCR=1.2,每年可减少1238人发病,减少19468.85个工作日损失,每年产生净效益1141.16万元。结论在人群中实施甲肝、乙肝、伤寒疫苗预防接种能产生巨大的经济效益和社会效益。
Objective To analysis the cost-benefit ratio（BCR） for hepatitis A vaccine,hepatitis B vaccine and typhus vaccine immunization and provide the reference for making the immunity vaccination strategy aiming at different vaccine and different population in Kunming.Methods The immunity vaccination cost benefit was analyzed by collecting the medical expenditure for hepatitis A,hepatitis B and typhus in recent years in Kuming.Results This research altogether investigated the sample 12563 examples,including hepatitis A 1337 examples,hepatitis B 1881 examples and typhus 941 examples. The results showed that the BCR of hepatitis A vaccine was 1.79 according to vaccine inoculation＇s cost benefit analysis,which could make 1827 persons avoid being taken bad every year,and produce 15,789,800 Yuan every year.The BCR of hepatitis B vaccine was 1.80,which could make 3546 persons avoid becoming the hepatitis B virus infected person every year,and reduce 77877.74 working days the losses,and produce 30,024,000 Yuan every year.The BCR of typhus vaccine was 1.2,which could reduce 1238 persons to be taken bad every year,and reduce 19468.85 working days to lose,and produce 11,411,600 Yuan every year.Conclusion Vaccination hepatitis A vaccine,Vaccination hepatitis B vaccine and typhus vaccine can produce the huge economic efficiency and the social efficiency.
出处
《中国健康教育》
2008年第7期489-492,500,共5页
Chinese Journal of Health Education
关键词
甲肝
乙肝
伤寒
成本效益
Hepatitis A
Hepatitis B
Typhus
Cost-benefit ratio（BCR）
